In CML patients and a murine CML model, LSCs were found to express CD27 which stimulated colony formation, proliferation and cell cycle progression via TRAF2/TNIK-mediated Wnt/β-catenin-pathway activation [123]. The gene discussed is TRAF2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.